Work

A Phase I Study of BKM120 (Buparlisib) and Rituximab in Patients with Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma (NHL)

Year: 2015

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v126.23.5114.5114

Authors: Kami J. Maddocks, Jonathon B. Cohen, Beth A Christian, Don M Benson, Kristie A. Blum

Institutions: The Ohio State University, Emory University, Winship Cancer Institute

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2475736659

FWCI: 0.968

Cites:

Cited by: 5

Related to: 10